BEAM-101 and BEAM-102 Named as Development Candidates Targeting Distinct Approaches to Treating Sickle Cell DiseaseLease Agreement Signed to Build In-house […]
RESEARCH TRIANGLE PARK, N.C., Aug. 12, 2020 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, today announced that […]